RegLink's principals draw on decades of first-hand experience in the drug, biotech, biologicals, generics and medical device sectors, having worked both for and within regulatory bodies and industry, domestically and internationally. In the mid-90s, we collaborated in the transition away from hard copy by developing the first digital reference libraries covering the U.S. FDA and the then newly-created European Medicines Agency. The creation of RegLink News and the development of its global drug and device regulatory and policy information and briefing services evolved from that early collaborative effort.
Advisory Board and Expert Network
RegLink's Advisory Board members and its network of experts are personable and professionally successful individuals widely respected and recognized by their peers. It has been our good fortune to work with and to get to know each of them personally in the course of our respective careers. They have kindly agreed to be a resource for us, and we have no doubt that they can be for you as well.